Finance Lead, FP&A & Business Insights (Dermatology)

AbbVie; Mettawa (IL); On-site; USD 120,000 - 180,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

Vision insurance

401(k)

Paid time off

Short-term incentive eligibility

Job summary

AbbVie is seeking a Finance Lead for Immunology Finance supporting Dermatology FP&A. You will oversee planning, LBEs, LRP, and actuals processes, ensuring accurate reporting and business insights across brand teams.

You will partner with senior leaders, manage monthly closes and headcount analysis, and drive process improvements while ensuring adherence to financial policies across the US Dermatology portfolio.

Qualifications

• Bachelor's degree in Finance or Accounting required.
• CPA or MBA a plus.
• 6+ years of progressive experience in finance.
• Strong analytical and problem solving skills.
• Strong written and verbal communication skills.
• Advanced Excel skills; SAP and TM1 knowledge is a plus.

Responsibilities

• Track US Dermatology budgets and analyze results vs Plan/LBEs to identify risks/opportunities.
• Lead Plan/LBE/LRP planning processes with clear, management-ready deliverables.
• Perform monthly close activities including headcount reporting and variance analysis; prepare management packages.
• Partner with BU VP and brand leads to deliver accurate, meaningful financials.
• Lead financial reviews and approvals (POs and invoices).
• Lead and support ad hoc analysis and process improvements.

Skills

FP&A

Budgeting

Financial analysis

Headcount reporting

Communication

Excel

SAP

TM1

Education

Bachelor's degree in Finance or Accounting

CPA or MBA a plus

Tools

SAP

TM1

Excel

Job description

AbbVie is seeking a Finance Lead for Immunology Finance supporting Dermatology FP&A. You will oversee planning, LBEs, LRP, and actuals processes, ensuring accurate reporting and business insights across brand teams.

You will partner with senior leaders, manage monthly closes and headcount analysis, and drive process improvements while ensuring adherence to financial policies across the US Dermatology portfolio.